NASDAQ:AUPH
Aurinia Pharmaceuticals Inc Stock News
$5.21
-0.0300 (-0.573%)
At Close: May 24, 2024
Analysts Offer Insights on Healthcare Companies: Entasis Therapeutics Holdings (NASDAQ: ETTX) and Zynerba Pharmaceuticals (NASDAQ: ZYNE)
11:13am, Thursday, 12'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entasis Therapeutics Holdings (
ETTX
–
Research Report
) and Zynerba Pharmaceuticals (
ZYNE
–
Resea
Akebia Therapeutics (AKBA) Received its Third Buy in a Row
11:31am, Wednesday, 11'th Mar 2020
After Mizuho Securities and Piper Sandler gave Akebia Therapeutics (NASDAQ: AKBA) a Buy rating last month, the company received another Buy, this time
Akebia Therapeutics (AKBA) Received its Third Buy in a Row
11:31am, Wednesday, 11'th Mar 2020
After Mizuho Securities and Piper Sandler gave Akebia Therapeutics (NASDAQ:
AKBA
) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst
Ed Arce
maintained
Analysts Offer Insights on Healthcare Companies: InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK)
11:31am, Wednesday, 11'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InspireMD (NSPR) and Paratek Pharmaceuticals (PRTK) with
Analysts Offer Insights on Healthcare Companies: InspireMD (NYSE MKT: NSPR) and Paratek Pharmaceuticals (NASDAQ: PRTK)
11:31am, Wednesday, 11'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on InspireMD (
NSPR
–
Research Report
) and Paratek Pharmaceuticals (
PRTK
–
Research Report
) with bu
Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH), BioCryst (BCRX) and Flexion Therapeutics (FLXN)
05:04pm, Monday, 09'th Mar 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (AUPH), BioCryst (BCRX) and Flexion Therapeutics
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Aurinia Pharmaceuticals (
AUPH
–
Research Report
), BioCryst (
BCRX
–
Research Report
) and Flexion Therapeutics (
Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT) and Aurinia Pharmaceuticals (AUPH)
12:23pm, Friday, 06'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on EyePoint Pharmaceuticals (EYPT) and Aurinia
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on EyePoint Pharmaceuticals (
EYPT
–
Research Report
) and Aurinia Pharmaceuticals (
AUPH
–
Research R
Cantor Fitzgerald Maintains Overweight on Aurinia Pharmaceuticals, Raises Price Target to $32
12:00am, Friday, 06'th Mar 20207 Stocks Moving In Thursday's After-Hours Session
10:22pm, Thursday, 05'th Mar 2020
Gainers
Okta (NASDAQ: OKTA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company issued Q1 and FY21 sales guidance...
Aurinia Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.
12:00am, Thursday, 05'th Mar 2020H.C. Wainwright Maintains Their Buy Rating on Arcturus Therapeutics (ARCT)
05:14pm, Wednesday, 04'th Mar 2020
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Arcturus Therapeutics (ARCT), with a price target of $18.00. The
H.C. Wainwright Maintains Their Buy Rating on Arcturus Therapeutics (ARCT)
05:14pm, Wednesday, 04'th Mar 2020
In a report released today,
Ed Arce
from H.C. Wainwright maintained a
Buy
rating on Arcturus Therapeutics (
ARCT
–
Research Report
), with a price target of
$18.00
. The company’s shares closed la
